Oncology Fundamentals Day for Technicians 2019 Session Descriptions

Cancer Treatment Basics - Colleen Olson, Saskatoon Cancer Centre, Saskatoon, SK

Speaker Biography

Cancer treatments have evolved at a rapid pace over the last 10 years with newer agents aimed at specific molecular targets in the cancer cell growth cycle and more recently agents that are focused on harnessing the patient’s own immune system.  This presentation will review  “traditional” cytotoxic chemotherapy agents that continue to have an important role in the treatment of cancer and how they compare to newer agents.

Learning Objectives:

  1. Overview of the mechanism of actions of cytotoxic chemotherapy, targeted therapy and checkpoint inhibitor therapy agents;
  2. Common toxicities by class of agent;
  3. Discuss the rationale for the different schedules of administration for different treatment regimens; and
  4. How do granulocyte colony stimulation factors (GCSF) work? And what are the guidelines for use.

Hereditary Cancer Syndromes for the Non-Genetics Health Care Provider - Andrea Hawrysh, Division of Genetics at Royal University Hospital, Saskatchewan Health Authority, Saskatoon, SK

Speaker Biography

Inherited forms of cancer are rare. However, the identification of individuals with an inherited form of cancer can have far reaching impact in the clinical management of the individual and their family members. This presentation will provide the non-genetics health care worker with a general understanding of the role and process of genetic testing in an Oncology setting.  

Learning Objectives:

  1. Understand the key differences between somatic and germline mutations; 
  2. Compare and contrast sporadic, familial and inherited forms of cancer; and
  3. Identify potential risks, benefits and limitations of genetic testing.

                                                                                                                                                                                                                                                                                                             Back to top

Proposed Updates to USP Chapter <797> - Eric Kastango, Clinical IQ LLC & Critical Point LLC, Madison, New Jersey

Speaker Biography

The current USP Chapter <797> has not changed since June 1, 2008.  On July 27, 2018, USP pre-post the second proposed revision to USP Chapter <797>.  This is a long-awaited release since the last revision issued in October 2015.  Having received over 8,000 public comments from stakeholders, it is expected that the Chapter has undergone significant revision from the 2015 version.  Join industry expert Eric S. Kastango for a comprehensive overview of the significant changes in the latest revision to USP Chapter <797>.

Discussion will include:

  • The two categories of compounded sterile preparations, Category 1 and Category 2 and relevant requirements
  • Personnel qualifications
  • Primary and Secondary Engineering Controls and Segregated Compounding Areas
  • Viable Environmental Monitoring
  • Cleaning and Disinfection
  • Beyond Use Dating      

Learning Objectives:

  1. Describe how the changes made to risk levels, going from three levels to two categories of compounded sterile preparations, Category 1 and Category 2 will affect compounding practices;
  2. Explain the Primary and Secondary Engineering Controls and Segregated Compounding Areas as described in the proposed revision of USP Chapter <797> ; and
  3. Describe the clarified Cleaning and Disinfection section of the chapter.

Technicians Checking Chemotherapy: Development of a Safe System - Kara Browne, Saskatoon Cancer Centre, Saskatoon, SK

Speaker Biography

Patients receiving cancer chemotherapy are thought to be at a higher risk of serious, potentially devastating errors than patients receiving other medications.  In addition, several studies have shown that there is a significant degree of risk for error in manual IV mixing practices. As the pharmacy team members’ scope of practice changes, complex tasks such as performing the final check for prepared sterile preparations may be shifted from Pharmacists, to Licensed Pharmacy Technicians.  In oncology, such a shift in responsibilities may lead to workflow efficiencies, but may also cause concerns about patient risk and medication errors.  This presentation will describe the development and implementation of a safe system for IV chemotherapy preparation and checking.

Learning Objectives:

  1. Describe common IV preparation practices which may lead to errors;
  2. Discuss the strategies used to mitigate the common error-prone IV preparation practices; and
  3. Outline the development and implementation of a Chemotherapy Checking Certification Program.

                                                                                                                                                                                                                                                                                                             Back to top

Pharmacy Technician Drug Access Navigator: Connecting Oncology Patients with Treatment Options - Chris Jensen, BC Cancer, Vancouver, BC

Speaker Biography

Many Canadians find themselves being asked to pay out of pocket for their cancer medications, as not all cancer treatment is funded in Canada. These medications can routinely cost ten thousand dollars per month, or more. This financial burden is often more than patients and their families can and should have to bear. This presentation will introduce healthcare professionals to the role of the Drug Access Navigator (DAN), and what support the DAN can provide to patients who require access to financial assistance options for unfunded medications. 

Learning Objectives:

  1. Explain the value of the Drug Access Navigator role from both a patient and healthcare point of view;
  2. Identify potential options for obtaining financial assistance for patients; and
  3. Describe the benefits and setbacks of Patient Assistance Programs.

                                                                                                                                                                                                                                                                                                             Back to top